Filter
770
Filtered Results: 770
Text search:
drug
manufacturing
Featured
Recommendations
59
New Publications
189
Language
Document type
No document type
364
Studies & Reports
152
Guidelines
134
Manuals
46
Strategic & Response Plan
42
Fact sheets
12
Situation Updates
9
Training Material
5
Resource Platforms
3
Infographics
2
Brochures
1
Countries / Regions
Global
37
India
36
Kenya
33
Ghana
21
Nigeria
21
Uganda
19
Ethiopia
18
Western and Central Europe
14
South Africa
14
Sierra Leone
13
Tanzania
13
Bangladesh
13
Nepal
12
Africa
12
Zambia
12
Lesotho
9
Malawi
9
Botswana
9
Ukraine
8
Zimbabwe
8
Liberia
8
Rwanda
7
South–East Asia Region
7
Namibia
7
Myanmar / Burma
7
Philippines
6
Latin America and the Carribbean
5
Eastern Europe
5
Indonesia
5
Eswatini/ Swaziland
4
Tajikistan
3
Thailand
3
Albania
3
Haiti
3
Cambodia
3
West and Central Africa
3
East and Southern Africa
3
Russia
3
Cameroon
2
Laos
2
Senegal
2
Mozambique
2
Asia
2
Germany
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Vietnam
2
Moldova
2
Sudan
2
Pakistan
2
Serbia
1
Australia
1
Benin
1
China
1
Syria
1
Burkina Faso
1
Uzbekistan
1
Mongolia
1
Guinea
1
USA
1
Congo, Democratic Republic of
1
Middle East and North Africa
1
Turkmenistan
1
Maldives
1
Mauritius
1
Brazil
1
Sri Lanka
1
South Sudan
1
Iraq
1
Solomon Islands
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
312
Clinical Guidelines
61
Pharmacy & Technologies
33
Public Health
28
Key Resources
20
Women & Child Health
13
Capacity Building
7
Toolboxes
Pharmacy
85
AMR
85
COVID-19
54
HIV
48
TB
41
Mental Health
34
Malaria
23
NTDs
20
Planetary Health
17
NCDs
15
Ebola & Marburg
14
Health Financing Toolbox
12
Global Health Education
12
Rapid Response
11
Caregiver
7
Specific Hazards
6
2.0 Rapid Response
5
Conflict
5
Cholera
4
Natural Hazards
3
Polio
2
Refugee
1
Disability
1
Zika
1
This is the first NAP on the Prevention and Containment of AMR in Kenya. It has been developed based on the National Policy on Prevention and Containment of AMR and the recommendations of the situation analysis on AMR conducted in 2011 and updated in 2016. This strategy provides a regulatory and imp...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
Towards a Healthier Botswana
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically assist national medicines regulatory authorities to...
Full Report
Access to controlled medicines. 3rd edition
Technical Report
AIDS Medicines and diagnostics service
July 2015
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha...
Promoting People's Health to Enhance Social-economic Development
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards
the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized ...
